The relationship between hemostatic tests and cardiovascular risk factors in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities (ECAT) Angina Pectoris Group.
Baseline data are presented of the ECAT Angina Pectoris Study. Both plasminogen activator inhibitor and fibrinogen were positively associated with a number of cardiovascular risk factors such as smoking, body mass index, and also with the presence of coronary stenosis. Results indicate a role of the hemostatic system in the progress of coronary arteriosclerosis.
Haverkate
F
F
Gaubius Laboratory IVVO-TNO, Leiden, The Netherlands.
Thompson
S G
SG
van de Loo
J C
JC
D000787:Angina Pectoris / Q000097:blood*; D001780:Blood Coagulation Tests; D003324:Coronary Artery Disease / Q000097:blood*; D003430:Cross-Sectional Studies; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D005342:Fibrinolysis; D006487:Hemostasis; D006801:Humans; D008297:Male; D008875:Middle Aged; D015849:Plasminogen Inactivators / Q000032:analysis; D010978:Platelet Factor 4 / Q000032:analysis; D012307:Risk Factors; D013927:Thrombosis / Q000097:blood; D010959:Tissue Plasminogen Activator / Q000032:analysis; D001620:beta-Thromboglobulin / Q000032:analysis
D015849:Plasminogen Inactivators; D001620:beta-Thromboglobulin; D010978:Platelet Factor 4; D005340:Fibrinogen; D010959:Tissue Plasminogen Activator